Transient activation of Nrf2 blocks this mechanism, and in fact, Nrf2 activators, such as sulforaphane, epigallocatechin-3-gallate, and curcumin, may be a good therapeutic option for acute and CKD [100,101,102,103] (Table 1). Here, NFE2L2 is linked to chronic kidney disease.